FDA recall D-600-2013

OLAAX International · Class I · drug

Product

MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL

Reason for recall

Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.

Distribution

Nationwide, Puerto Rico and Venezuela and Bolivia

Key facts

Status
Terminated
Initiation date
2013-02-12
Report date
2013-06-19
Termination date
2019-10-01
Voluntary/Mandated
Voluntary: Firm initiated
Location
Bartow, FL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-600-2013